SCHEMBL17231920

SCHEMBL17231920

Cc1cc(C(=O)OCc2ccccc2)n(C(=O)OC(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.43
KMT2A Q03164 2/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
SYK P43405 1/20 0.42
MAPT P10636 4/20 0.41
ALDH1A1 P00352 5/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
GPBAR1 Q8TDU6 1/20 0.41
LMNA P02545 1/20 0.40
ELANE P08246 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPY1R P25929 1/20 0.40
MAOB P27338 1/20 0.40
ADORA2A P29274 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2512518 0.88 TDP1 (0.41) TDP1KMT2ASLC6A2SLC6A3CRHBP
SCHEMBL1971320 0.86 TACR1 (0.45) TDP1KMT2ASLC6A2SLC6A3SYK
SCHEMBL2508975 0.81 LIPG (0.36) TDP1KMT2ASLC6A2SLC6A3L3MBTL1
SCHEMBL9908201 0.80 RAB9A (0.36) TDP1KMT2ASLC6A2SLC6A3L3MBTL1
SCHEMBL10225709 0.79 TDP1 (0.48) TDP1KMT2ASLC6A2SLC6A3L3MBTL1
SCHEMBL14164204 0.77 NR1H2 (0.44) TDP1KMT2AL3MBTL1MAPTLMNA
SCHEMBL17231919 0.76 BUB1 (0.38) KMT2AL3MBTL1MAPTLMNAKDM4E
SCHEMBL17766688 0.75 MMP9 (0.40) TDP1KMT2AL3MBTL1MAPTALDH1A1
SCHEMBL28740303 0.75 JMJD6 (0.44) TDP1KMT2ASLC6A2SLC6A3L3MBTL1
SCHEMBL427684 0.75 TDP1 (0.43) TDP1KMT2ASLC6A2SLC6A3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9469608-B2 Thrombin inhibitors MERCK SHARP & DOHME CORP. (US) 2016-10-18 US disclosed
US-20150315141-A1 Thrombin Inhibitors MERCK SHARP & DOHME CORP. (US) 2015-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150315141-A1 Thrombin Inhibitors F3, F2, F9 TDP1 2911/4885KMT2A 1536/4885SLC6A2 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.